US Stock MarketDetailed Quotes
MRKR Marker Therapeutics
- 4.0200
- -0.0900-2.19%
Close May 7 16:00 ET
35.83MMarket Cap-4276P/E (TTM)
4.3200High4.0200Low13.48KVolume4.1100Open4.1100Pre Close55.99KTurnover0.20%Turnover RatioLossP/E (Static)8.91MShares9.679952wk High2.55P/B27.17MFloat Cap1.160052wk Low--Dividend TTM6.76MShs Float2447.9980Historical High--Div YieldTTM7.30%Amplitude0.6700Historical Low4.1540Avg Price1Lot Size
About Marker Therapeutics Company
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Company Profile
SymbolMRKR
Company NameMarker Therapeutics
Listing DateNov 7, 2016
Founded1991
CEODr. Juan Vera, M.D.
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4551 Kennedy Commerce Drive
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77032
Phone1-713-400-6400
Company Executives
- Name
- Position
- Salary
- Dr. Juan Vera, M.D.
- Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
- 585.25K
- N. David Eansor
- Chairman of the Board
- 124.04K
- Steven A. Elms
- Independent Director
- 76.14K
- John Wilson
- Independent Director
- 63.44K
- Dr. Katharine Knobil, M.D.
- Independent Director
- 79.67K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg